Patent Assignment
Reel/Frame 055165/0938
Assignment of Assignor's Interest
Recorded: 2021-02-05
Pages: 6
Assignee
COHERUS BIOSCIENCES, INC.
333 TWIN DOLPHIN DRIVE, SUITE 600, REDWOOD CITY, CALIFORNIA, 94065
Covered Properties
(3)
High Concentration Formulations of Adalimumab
Patent:
11,229,702 →
Application:
15/337,519 →
High Concentration Formulations of Adalimumab
Application:
62/247,348 →
High Concentration Formulations of Adalimumab
Application:
62/413,226 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jan 7, 2019
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
To: HCR COLLATERAL MANAGEMENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 048021/0975 →
Release of Notice of Grant of Security Interest in Patents at Reel/Frame No. 048021/0975
Jan 11, 2022
From: HCR COLLATERAL MANAGEMENT, LLC
To: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.
Reel/Frame 058692/0665 →
Security Interest
May 8, 2024
From: COHERUS BIOSCIENCES, INC.; COHERUS INTERMEDIATE CORP.; INTEKRIN THERAPEUTICS INC.; SURFACE ONCOLOGY, LLC
To: ANKURA TRUST COMPANY, LLC
Reel/Frame 067348/0160 →
Assignment of Assignor's Interest
Oct 31, 2024
From: COHERUS BIOSCIENCES, INC.
To: HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
Reel/Frame 069084/0884 →